HeartSciences (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences (HSCS) has reported Share-based Compensation for 6 consecutive years, with $324841.0 the latest figure, recorded in Q2 2026.

• Quarterly Share-based Compensation rose 238.57% year-over-year to $324841.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $649898.0 (up 88.63% YoY) and the FY2026 annual result came in at $1.3 million, up 228.1% from the prior year.
• Share-based Compensation eased to $324841.0 in Q2 2026 per HSCS's latest filing, from $1.5 million in the prior quarter.
• Over the last five years, Share-based Compensation for HSCS reached as high as $1.7 million in Q4 2022 and fell as low as -$49853.0 in Q2 2022.
• A 5-year average of $844244.7 and a median of $912420.5 in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 210172.28% — and 2023, when it plunged 91.69%.
• Year by year, Share-based Compensation stood at $1.7 million in 2022, then fell by 5.83% to $1.6 million in 2023, then retreated by 6.25% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then sank by 78.34% to $324841.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $324841.0, $1.5 million, and $174558.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.